U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Mon Mar 31 22:06:38 GMT 2025
Edited
by admin
on Mon Mar 31 22:06:38 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
29Y3UO9LWK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANTITHROMBIN GAMMA (GENETICAL RECOMBINATION)
JAN  
Preferred Name English
ANTITHROMBIN GAMMA
INN   WHO-DD  
INN  
Official Name English
AFUCOSYLATED ANTITHROMBIN
Common Name English
ANTITHROMBIN (HUMAN VARIANT KW-3357)
Common Name English
ANTITHROMBIN GAMMA [JAN]
Common Name English
antithrombin gamma [INN]
Common Name English
ACOALAN
Brand Name English
Antithrombin gamma [WHO-DD]
Common Name English
HUMAN ANTITHROMBIN-III (ATIII, SERPIN C1) EXPRESSED IN FUCOSYL TRANSFERASE-NEGATIVE CHINESE HAMSTER OVARY (CHO) CELLS (GLYCOFORM GAMMA)
Common Name English
Code System Code Type Description
SMS_ID
100000166684
Created by admin on Mon Mar 31 22:06:38 GMT 2025 , Edited by admin on Mon Mar 31 22:06:38 GMT 2025
PRIMARY
FDA UNII
29Y3UO9LWK
Created by admin on Mon Mar 31 22:06:38 GMT 2025 , Edited by admin on Mon Mar 31 22:06:38 GMT 2025
PRIMARY
CAS
1311281-25-0
Created by admin on Mon Mar 31 22:06:38 GMT 2025 , Edited by admin on Mon Mar 31 22:06:38 GMT 2025
PRIMARY
INN
9591
Created by admin on Mon Mar 31 22:06:38 GMT 2025 , Edited by admin on Mon Mar 31 22:06:38 GMT 2025
PRIMARY
EVMPD
SUB180936
Created by admin on Mon Mar 31 22:06:38 GMT 2025 , Edited by admin on Mon Mar 31 22:06:38 GMT 2025
PRIMARY
NCI_THESAURUS
C166560
Created by admin on Mon Mar 31 22:06:38 GMT 2025 , Edited by admin on Mon Mar 31 22:06:38 GMT 2025
PRIMARY
JAPANESE REVIEW
Acoalan
Created by admin on Mon Mar 31 22:06:38 GMT 2025 , Edited by admin on Mon Mar 31 22:06:38 GMT 2025
PRIMARY APPROVED JULY 2015
From To
1_8 1_128
1_21 1_95
1_247 1_430
Glycosylation Type MAMMALIAN, AFUCOSYLATED
Glycosylation Link Type Site
N 1_96
N 1_135
N 1_155
N 1_192
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
amino acid substitution [1_36] Ser DEXFOSFOSERINE VI4F0K069V
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL